Refractory Relapsed Multiple Myeloma clinical trials

Explore recruiting refractory relapsed multiple myeloma clinical trials.

Recruiting refractory relapsed multiple myeloma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Relapsed Multiple Myeloma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Teclistamab plus autologous lymphocytes infusion for the treatment of relapsed/refractory Multiple Myeloma (TALIM). MM0125

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Refractory Relapsed Multiple Myeloma trials by city

Refractory Relapsed Multiple Myeloma in Toronto Refractory Relapsed Multiple Myeloma in Vancouver Refractory Relapsed Multiple Myeloma in Montreal Refractory Relapsed Multiple Myeloma in Calgary Refractory Relapsed Multiple Myeloma in Edmonton Refractory Relapsed Multiple Myeloma in Ottawa Refractory Relapsed Multiple Myeloma in Winnipeg Refractory Relapsed Multiple Myeloma in Quebec City Refractory Relapsed Multiple Myeloma in Hamilton Refractory Relapsed Multiple Myeloma in Kitchener Refractory Relapsed Multiple Myeloma in London Refractory Relapsed Multiple Myeloma in Halifax Refractory Relapsed Multiple Myeloma in New York Refractory Relapsed Multiple Myeloma in Los Angeles Refractory Relapsed Multiple Myeloma in Chicago Refractory Relapsed Multiple Myeloma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease